Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
AOD-9604 is a modified fragment of the C-terminal chain of human growth hormone (hGH) , covering amino acids 177 to 191
AOD 9604 clinical evidence The most rigorous AOD 9604 data comes from the Metabolic Pharmaceuticals clinical program conducted between 2001 and 2007
Australian Securities Exchange filing, February 2007
AOD-9604 isolates only the fat-tissue effects without the broader hormonal cascade
AOD 9604, as a local fat loss drug, can precisely act on adipose tissue and reduce fat accumulation, and is expected to meet the market demand for safe and effective weight loss drugs
This comprehensive analysis examines the clinical trial evidence for AOD-9604s safety profile, including participant numbers, study designs, reported adverse effects, metabolic safety markers, immunogenicity data, and how this peptides safety characteristics compare to related therapies
US$ 26.92
US$ 22.72
US$ 23.24
US$ 28.18
US$ 21.74
US$ 25.22
US$ 23.50
US$ 24.63
US$ 279500.00
Sold : Login>>
